This is Quest's brand manual covering editorial style guidelines.

This quick-hit flyer for physicians explains Quest's policy of strongly encouraging appointments during the pandemic.

This brochure for physicians covers the benefits of drug monitoring testing for women's health.

This is the instruction booklet included in Quest's at-home COVID-19 testing kit.

This consumer-facing brochure discusses prenatal genetic testing.

This case study discusses strategies and initativies used by two health plans affiliated with Integrated delivery networks (IDNs) to achieve high-performance in diabetes 5-star quality measures. Stakeholders who may be interested in this study include: Quality directors Medical directors Pharmacy directors

Help Your Patients Step Forward to a Solid Foundation with Adcirca(TM) A first-line PDE-5 inhibitor that can help improve exercise ability

Enrollment in the Insurance Marketplace: Tips and Tools to Help Your Constituents Succeed There are 4 basic types of Marketplace plans: Bronze, Silver, Gold, and Platinum. Here are 3 essential questions your constituents must answer when selecting a health plan: What can they afford to pay for their benefits? Is their doctor in a health plan's network? Which prescription drugs do they take?

Your comprehensive guide to obtaining STELARA® for your appropriate patients. Specialty products like STELARA® may be covered for your patients under the medical benefit, the pharmacy benefit, or both. It’s important to investigate both benefits to ensure seamless processing and timely delivery of STELARA® to your patients.

Janssen Biotech, Inc., is committed to providing you and your office staff with detailed information to assist you in obtaining reimbursement for DARZALEX™ (daratumumab). This Reimbursement and Access Guide has been developed to provide you with information regarding: • Essential Coding Considerations • Sample Claims Forms • A list of Specialty Distributors • Important Product Information • Reimbursement Support Services

This presentation was developed to educate payers, policy makers, and advocates on: -HCV treatment landscape and the high unmet within genotype 3 -DAKLINZA efficacy and safety outcomes from the ALLY 3 trial -Economic considerations for DAKLINZA

The Patient Protection and Affordable Care Act (ACA) calls for the creation of health insurance exchanges, or online marketplaces where individuals and small businesses can purchase health insurance. Most uninsured will be required to have health insurance beginning in 2014, with as many as 24 million Americans expected to enroll in the exchange by 2023. This guide is designed to expand your understanding of the exchange in order to facilitate and enrich your discussions with customers.